For example, among patients with acute coronary syndrome, women have a higher 1-year risk of atherothrombotic events than men, particularly female carriers of the CYP2C9*3 loss-of-function allele, indicating a possible gender-by-genotype interaction in clopidogrel responsiveness [47]. Here, CYP2C9 is linked to acute coronary syndrome.